Filing Flows › Cumberland Pharmaceuticals (CPIX) › Recalls, complaints & regulation
Cumberland Pharmaceuticals (CPIX): clinical trials
Cumberland Pharmaceuticals (CPIX) beyond its filings: 2 active clinical trials.
Cumberland Pharmaceuticals' latest quarter
Cumberland Pharmaceuticals, Q2 2026: revenue $8.8M (-19% year over year), operating margin -35.9%, net loss $4.3M, operating cash flow $169K. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Cumberland Pharmaceuticals have?
2 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.